Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Abstract 4089: Time to treatment discontinuation and time to next treatment as proxies of real-world progression-free survival in breast cancer patients

Monika A. Izano, Mahder Teka, Colden Johanson, Jeanna Wallenta Law, Ronda Broome, Daniele Morgan, Amy Stone, Mary Tran, Thomas D. Brown, Chenan Zhang

Cancer Res (2022) 82 (12_Supplement): 4089.

https://doi.org/10.1158/1538-7445.AM2022-4089

Published: 15 June 2022

View articletitled, Abstract 4089: Time to treatment discontinuation and time to next treatment as proxies of real-world progression-free survival in breast cancer patients

Journal Articles

Abstract 445: Natural history of coagulopathy in patients with cancer infected with COVID19: A real-world data (RWD) analysis

Jeanna Wallenta Law, Danny Idyro, Andrew Schrag, Frank Wolf, Thomas D. Brown

Cancer Res (2022) 82 (12_Supplement): 445.

https://doi.org/10.1158/1538-7445.AM2022-445

Published: 15 June 2022

View articletitled, Abstract 445: Natural history of coagulopathy in patients with cancer infected with COVID19: A real-world data (RWD) analysis

Journal Articles

Abstract 6259: Molecular biomarker testing and targeted therapy patterns in patients with acute myelogenous leukemia (AML): A real-world data analysis

Jeanna Wallenta Law, Zartash Gul, Anna Berry, Michael A. Thompson, Christopher Willner, Sowjanya Vuyyala, Haley McCracken, Katherine Geverd, Frank M. Wolf, Thomas D. Brown, Philip Kuriakose

Cancer Res (2022) 82 (12_Supplement): 6259.

https://doi.org/10.1158/1538-7445.AM2022-6259

Published: 15 June 2022

View articletitled, Abstract 6259: Molecular biomarker testing and targeted therapy patterns in patients with acute myelogenous leukemia (AML): A real-world data analysis

Journal Articles

Abstract P3-14-17: Exploring racial disparities in BRCA testing for triple negative breast cancer patients: A real-world data analysis

Jeanna Wallenta Law, Hanadi BuAli, Sherri Costa, Michael P. Mullane, Mohamed Hendawi, Michael McPhee, Bryanne Collini, Mahder Teka, Francesca Coutinho, Ronda Broome, Frank M. Wolf, Liz Toland, Trista Weber, Anna Berry, Thomas D. Brown, Haythem Ali

Cancer Res (2022) 82 (4_Supplement): P3-14-17.

https://doi.org/10.1158/1538-7445.SABCS21-P3-14-17

Published: 15 February 2022

View articletitled, Abstract P3-14-17: Exploring racial disparities in BRCA testing for triple negative breast cancer patients: A real-world data analysis

Journal Articles

Abstract 2618: Staged analysis of standard of care tumor molecular testing among patients with metastatic colorectal cancer in the community health system setting

Chenan Zhang, Mahder Teka, Francesca F. Coutinho, Joseph R. Burkhart, Louise E. Widmer, Ronda G. Broome, Mary T. Tran, Michael A. Thompson, Antony M. Ruggeri, Jennifer J. Godden, James L. Weese, Douglas J. Reding, Anna B. Berry, Yanina Natanzon, Thomas D. Brown

Cancer Res (2021) 81 (13_Supplement): 2618.

https://doi.org/10.1158/1538-7445.AM2021-2618

Published: 01 July 2021

View articletitled, Abstract 2618: Staged analysis of standard of care tumor molecular testing among patients with metastatic colorectal cancer in the community health system setting

Journal Articles

Abstract CT086: Pneumonitis incidence in patients with non-small cell lung cancer treated with immunotherapy or chemotherapy in clinical trials and real-world data

Qi Liu, Chenan Zhang, Yutao Gong, Hao Zhu, Elaine Chang, Cheryl Cho-Phan, Jonathan Hirsch, Michael A. Thompson, Gideon Blumenthal, Shiew Mei Huang, Thomas D. Brown

Cancer Res (2020) 80 (16_Supplement): CT086.

https://doi.org/10.1158/1538-7445.AM2020-CT086

Published: 15 August 2020

View articletitled, Abstract CT086: Pneumonitis incidence in patients with non-small cell lung cancer treated with immunotherapy or chemotherapy in clinical trials and real-world data

Journal Articles

Abstract 997: Impact of a personalized medicine research program (PMRP), using targeted tumor profiling and a cloud based clinical trials matching platform, on clinical decision-making

Thomas D. Brown, Paul D. Tittel, Philip J. Gold, Charles W. Drescher, John M. Pagel, J D. Beatty, Patra Grevstad, Desiree Iriarte, Shlece Alexander, Madeleine Brindle, Xiaoyu Liu, Donielle O'connor, Mariko Tameishi, Danbin Xu, Anna B. Berry

Cancer Res (2017) 77 (13_Supplement): 997.

https://doi.org/10.1158/1538-7445.AM2017-997

Published: 01 July 2017

View articletitled, Abstract 997: Impact of a personalized medicine research program (PMRP), using targeted tumor profiling and a cloud based clinical trials matching platform, on clinical decision-making

Journal Articles

A Phase I Clinical and Pharmacokinetic Trial of Hepsulfam

Peter M. Ravdin, Kathy A. Havlin, Milton V. Marshall, Thomas D. Brown, James M. Koeller, John G. Kuhn, Gladys Rodriguez, Daniel D. Von Hoff

Cancer Res (1991) 51 (23_Part_1): 6268–6272.

Published: 12 January 1991

View articletitled, A Phase I Clinical and Pharmacokinetic Trial of Hepsulfam

Journal Articles

Phase I and Clinical Pharmacology Trial of 502U83 Using a Monthly Single Dose Schedule

Daniel D. Von Hoff, John G. Kuhn, Kathleen A. Havlin, Anne-Marie Langevin, Thomas D. Brown, Geoffrey R. Weiss, Judy N. Turner, Joseph Purvis, V. Sol Lucas, Kenneth W. Bair, William Wargin, James Hubbell, Richard L. Tuttle, Jim M. Koeller, Gregory L. Freeman

Cancer Res (1990) 50 (23): 7496–7500.

Published: 01 December 1990

View articletitled, Phase I and Clinical Pharmacology Trial of 502U83 Using a Monthly Single Dose Schedule

Journal Articles

Phase I Clinical and Pharmacokinetic Trial of Brequinar Sodium (DUP 785; NSC 368390)

Carlos L. Arteaga, Thomas D. Brown, John G. Kuhn, Huey-Shin L. Shen, Timothy J. O'Rourke, Kenneth Beougher, H. James Brentzel, Daniel D. Von Hoff, Geoffrey R. Weiss

Cancer Res (1989) 49 (16): 4648–4653.

Published: 01 August 1989

View articletitled, Phase I Clinical and Pharmacokinetic Trial of Brequinar Sodium (DUP 785; NSC 368390)

Journal Articles

Phase I Study of α₂-Interferon plus Doxorubicin in Patients with Solid Tumors

Gisele A. Sarosy, Thomas D. Brown, Daniel D. Von Hoff, Robert J. Spiegel, James P. Golando, Kenneth L. Beougher, John G. Kuhn, Daniel L. Kisner

Cancer Res (1986) 46 (10): 5368–5371.

Published: 01 October 1986

View articletitled, Phase I Study of α2-Interferon plus Doxorubicin in Patients with Solid Tumors

Update search

NARROW

Format

Journal

Article Type

Issue Section

Date

Availability

Abstract 4089: Time to treatment discontinuation and time to next treatment as proxies of real-world progression-free survival in breast cancer patients

Abstract 445: Natural history of coagulopathy in patients with cancer infected with COVID19: A real-world data (RWD) analysis

Abstract 6259: Molecular biomarker testing and targeted therapy patterns in patients with acute myelogenous leukemia (AML): A real-world data analysis

Abstract P3-14-17: Exploring racial disparities in BRCA testing for triple negative breast cancer patients: A real-world data analysis

Abstract 2618: Staged analysis of standard of care tumor molecular testing among patients with metastatic colorectal cancer in the community health system setting

Abstract CT086: Pneumonitis incidence in patients with non-small cell lung cancer treated with immunotherapy or chemotherapy in clinical trials and real-world data

Abstract 997: Impact of a personalized medicine research program (PMRP), using targeted tumor profiling and a cloud based clinical trials matching platform, on clinical decision-making

A Phase I Clinical and Pharmacokinetic Trial of Hepsulfam

Phase I and Clinical Pharmacology Trial of 502U83 Using a Monthly Single Dose Schedule

Phase I Clinical and Pharmacokinetic Trial of Brequinar Sodium (DUP 785; NSC 368390)

Phase I Study of α₂-Interferon plus Doxorubicin in Patients with Solid Tumors

Email alerts

AACR Journals

Update search

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only